BRD2 and rectal cancer: In addition, a randomized controlled trial found that chemotherapy drugs can not only reduce the level of testosterone, but also increase the levels of follicle-stimulating hormone (FSH) and luteinizing hormone in the peripheral blood of patients with rectal cancer [11].